Zentalis Pharmaceuticals Inc ZNTL

NAS: ZNTL | ISIN: US98943L1070 5/12/2025

1,390 USD (-0,71%)

(-0,71%) 5/12/2025

Grafiek Zentalis Pharmaceuticals Inc

Grafiek Zentalis Pharmaceuticals Inc

1 dag1d -0,71%
1 week1w 1,46%
1 maand1m 5,30%
3 maanden3m -14,72%
6 maanden6m -6,71%
1 jaar1j -64,27%
5 jaar5j -97,60%

Zentalis Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

29 december 2022 · Moore Kuehn, PLLC Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm · Persbericht

10 maart 2021 · Zentalis Pharmaceuticals Announces Late-Breaker Oral Presentation on WEE1 Inhibitor, ZN-c3, at the AACR Annual Meeting 2021 · Persbericht

24 februari 2021 · Zentalis Pharmaceuticals to Present Initial Clinical Data on ZN-c3 at the AACR Annual Meeting 2021 · Persbericht

10 februari 2021 · Zentalis Pharmaceuticals Announces the Appointment of Dr. Enoch Kariuki to its Board of Directors · Persbericht

5 februari 2021 · Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences · Persbericht

Profiel Zentalis Pharmaceuticals Inc

Beleggingstrusts/Mutual Funds

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: zentalis.com

Hoofdzetel: New York, NY Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe